Impact of Crohn's perianal fistulas on healthcare resource utilization: a US chart review study.

Parakkal Deepak¹, Serre-Yu Wong², Alyssa M Parian³, Mark Sun⁴, Pradeep Nazarey⁵, Susan Cazzetta⁵, Brian Terreri⁵, Beni Turner⁶, Bridgett Goodwin⁵

¹Washington University School of Medicine, St. Louis, MO, USA.

²Icahn School of Medicine at Mount Sinai, New York, NY, USA.

³Johns Hopkins University School of Medicine, Baltimore, MD, USA.

⁴University of Minnesota, Minneapolis, MN, USA.

⁵Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.

⁶TriNetX, LLC, Cambridge, MA, USA.

PubMed DOI

Abstract

AIM: Perianal fistulas are a common complication of Crohn's disease. Despite the current treatment options, fistula recurrence/treatment failure rates are high. The aim of this study was to assess healthcare resource utilization (HCRU) among patients with new, persistent, and recurrent Crohn's perianal fistulas (CPF) in the USA. METHOD: A retrospective, multi-site medical chart review was conduct…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.